Kala Pharmaceuticals appoints Mark Iwicki to the Board of Directors as Executive Chairman
– USA, MA – Kala Pharmaceuticals, Inc. (Kala), a developer of innovative ophthalmic products based on its proprietary mucus-penetrating particle (MPP) technology, today announced the appointment of Mark Iwicki as Executive Chairman and a member of its board of directors.…